Newspaper/Magazine Article

FDA discusses oversight, regulation of HIT at ONC Workgroup hearing on patient safety.

This news article covers federal testimony in support of health information technology (HIT) system regulation by the United States Food and Drug Administration (FDA). The piece describes safety concerns that could result from HIT and discusses potential regulatory approaches to improvement, such as third-party reporting, confidentiality, and limited liability.